Novel Stearoyl CoA Desaturase 1 (SCD1) Inhibitors

Technology #2014-229

Questions about this technology? Ask a Technology Manager

Download Printable PDF

John A. Copland III Ph.D.
Christina Von Roemeling
Han W. Tun M.D.
Laura Ann Marlow
Thomas Caulfield Ph.D.
Managed By
Panya Taysavang
Patent Protection
US Patent Pending
US Patent Pending
US Patent Pending

Computer modeling followed by synthesis of novel compounds and testing for stearoyl CoA desaturase 1 (SCD1) specific growth inhibition of cancer cells has led to the identification of four novel lead SCD1 inhibitors.